{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:52:32Z","timestamp":1762606352516},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T00:00:00Z","timestamp":1386028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0078819","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T16:11:43Z","timestamp":1386087103000},"page":"e78819","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy and Safety of Dihydroartemisinin-Piperaquine for Treatment of Plasmodium vivax Malaria in Endemic Countries: Meta-Analysis of Randomized Controlled Studies"],"prefix":"10.1371","volume":"8","author":[{"given":"Cho","family":"Naing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Racloz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxine Anne","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyan","family":"Aung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon Andrew","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Wah","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,12,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2001.64.97","article-title":"The neglected burden of <italic>Plasmodium<\/italic> <italic>vivax<\/italic> malaria","volume":"64","author":"K Mendis","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1471-4922(02)02329-2","article-title":"Focus on <italic>Plasmodium<\/italic> <italic>vivax<\/italic>","volume":"18","author":"B Sina","year":"2002","journal-title":"Trends Parasitol"},{"key":"ref3","article-title":"Monitoring antimalarial drug resistance (Report of a WHO consultation 3rd-5th December 2001). Geneva (WHO\/CDS\/CSR\/EPH\/2002.17)","year":"2002"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.2007.77.79","article-title":"Vivax malaria: neglected and not benign","volume":"77","author":"RN Price","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0140-6736(98)09247-2","article-title":"Effects of <italic>Plasmodium<\/italic> <italic>vivax<\/italic> malaria in pregnancy","volume":"354","author":"F Nosten","year":"1999","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3201\/eid1307.061386","article-title":"Chloroquine resistant <italic>Plasmodium<\/italic> <italic>vivax<\/italic>, Brazilian Amazon","volume":"13","author":"FS de Santana Filho","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1475-2875-7-220","article-title":"Chloroquine-resistant <italic>Plasmodium<\/italic> <italic>vivax<\/italic> malaria in Debre Zeit, Ethiopia","volume":"7","author":"H Teka","year":"2008","journal-title":"Malar J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0035-9203(95)90556-1","article-title":"Development of resistance to chloroquine by <italic>Plasmodium<\/italic> <italic>vivax<\/italic> in Myanmar","volume":"89","author":"T Marlar","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1179\/000349804225021343","article-title":"Efficacy of chloroquine in the treatment of <italic>Plasmodium<\/italic> <italic>vivax<\/italic> malaria in Turkey","volume":"98","author":"MA Kurcer","year":"2004","journal-title":"Ann Trop Med Parasitol"},{"key":"ref10","article-title":"implementation of the global malaria control strategy. Report of a WHO study group on the implementation of the global plan of action for malaria control, 1993-2000","volume":"839","year":"1993","journal-title":"Technical Report Series"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.44.6.1680-1685.2000","article-title":"Therapeutic responses to different antimalarial drugs in vivax malaria","volume":"44","author":"S Pukrittayakamee","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","article-title":"Guidelines for the treatment of Malaria, 2nd ed","year":"2010"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1371\/journal.pmed.0020003","article-title":"Intermittent presumptive treatment for malaria","volume":"2","author":"NJ White","year":"2005","journal-title":"PLoS Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrmicro2239","article-title":"Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria","volume":"7","author":"RT Eastman","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/AAC.41.7.1413","article-title":"Assessment of the pharmacodynamic properties of antimalarial drugs in vivo","volume":"41","author":"NJ White","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1128\/AAC.05067-11","article-title":"Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and non-pregnant women with uncomplicated <italic>falciparum<\/italic> malaria","volume":"55","author":"MJ Rijken","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1475-2875-10-114","article-title":"Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria","volume":"10","author":"CA Morris","year":"2011","journal-title":"Malar J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.trstmh.2007.05.018","article-title":"Efficacy and safety of dihydroartemisinin-piperaquine","volume":"101","author":"HY Myint","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref19","article-title":"Artemisinin-based combination therapy for treating uncomplicated malaria","volume":"8","author":"D Sinclair","year":"2009"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/trstmh\/trs019","article-title":"Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated <italic>Plasmodium<\/italic> <italic>falciparum<\/italic> malaria in endemic countries: meta-analysis of randomized controlled studies","volume":"107","author":"C Naing","year":"2013","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2471\/BLT.09.072397","article-title":"Intermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan Africa","volume":"88","author":"I Carneiro","year":"2010","journal-title":"Bull World Health Org"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4269\/ajtmh.1991.45.479","article-title":"Infectious reservoir of <italic>plasmodium<\/italic> <italic>vivax<\/italic> and <italic>plasmodium<\/italic> <italic>falciparum<\/italic> malaria in an endemic region of Sri Lanka","volume":"45","author":"AC Gamage-Mendis","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"ref23","article-title":"Methods for surveillance of antimalarial drug efficacy","year":"2009"},{"key":"ref24","article-title":"Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 (updated March 2011)","author":"JPT Higgins","year":"2011"},{"key":"ref25","article-title":"GRADE handbook for grading quality of evidence and strength of recommendation, version 3.2 [updated March 2009]","author":"H Schunemann","year":"2009"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"MKB Parmar","year":"1998","journal-title":"Stat Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"JF Tierney","year":"2007","journal-title":"Trials"},{"key":"ref28","article-title":"Efficacy and safety of a fixed-dose dihydroartemisinin-piperaquine in treating uncomplicated Plasmodium vivax malaria: a systematic review and meta-analysis. CRD42013004625","year":"2013"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/432011","article-title":"A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant <italic>falciparum<\/italic> malaria","volume":"41","author":"EA Ashley","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1475-2875-9-105","article-title":"Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority","volume":"9","author":"GR Awab","year":"2010","journal-title":"Trial - Malar J"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1086\/512677","article-title":"Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant <italic>Plasmodium<\/italic> <italic>falciparum<\/italic> and <italic>Plasmodium<\/italic> <italic>vivax<\/italic> malaria","volume":"44","author":"AR Hasugian","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0804915","article-title":"A trial of combination antimalarial therapies in children from Papua New Guinea","volume":"11","author":"HA Karunajeewa","year":"2008","journal-title":"N Engl J Med"},{"key":"ref34","article-title":"A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of <italic>vivax<\/italic> malaria in Sumatra, Indonesia","author":"AP Pasaribu","year":"2013","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/cid\/cir631","article-title":"Dihydroartemisinin-piperaquine versus chloroquine in the treatment of <italic>Plasmodium<\/italic> <italic>vivax<\/italic> Malaria in Thailand: A randomized controlled trial","volume":"53","author":"AP Phyo","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(07)60160-3","article-title":"A Two fixed dose artemisinin combinations for drug-resistant <italic>falciparum<\/italic> and vivax malaria in Papua, Indonesia: an open-label randomized comparison","volume":"369","author":"A Ratcliff","year":"2007","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1473-3099(10)70187-0","article-title":"Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated <italic>falciparum<\/italic> malaria: an open-label randomized trial","volume":"10","author":"F Smithuis","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1475-2875-11-153","article-title":"Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia","volume":"11","author":"E Tjitra","year":"2012","journal-title":"Malar J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1128\/AAC.48.8.2966-2972.2004","article-title":"Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria","volume":"48","author":"HA Karunajeewa","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e6358","DOI":"10.1371\/journal.pone.0006358","article-title":"Safety and efficacy of dihydroartemisinin-piperaquine in <italic>falciparum<\/italic> malaria: a prospective multi-centre individual patient data analysis","volume":"4","author":"J Zwang","year":"2009","journal-title":"PLOS ONE"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.4269\/ajtmh.2010.10-0276","article-title":"A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated <italic>Plasmodium<\/italic> <italic>falciparum<\/italic> malaria in Southern Laos","volume":"83","author":"M Mayxay","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2125.2003.02004.x","article-title":"Population pharmacokinetics of piperaquine in adults and children with uncomplicated <italic>falciparum<\/italic> or vivax malaria","volume":"57","author":"T-Y Hung","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/AAC.00686-12","article-title":"Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated <italic>plasmodium<\/italic> <italic>falciparum<\/italic> and <italic>Plasmodium<\/italic> <italic>vivax<\/italic> in Cambodia, 2008 to 2010","volume":"57","author":"R Leang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/cid\/ciq249","article-title":"<italic>Plasmodium<\/italic> <italic>vivax<\/italic> recurrence following <italic>falciparum<\/italic> and mixed species malaria: risk factors and effect of antimalarial kinetics","volume":"52","author":"NM Douglas","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1128\/AAC.05877-11","article-title":"Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria","volume":"56","author":"KM Lwin","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.297.20.2201","article-title":"Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of <italic>Plasmodium<\/italic> <italic>vivax<\/italic> malaria in Afghanistan and Pakistan: a randomized controlled trial","volume":"297","author":"T Leslie","year":"2007","journal-title":"JAMA"},{"key":"ref47","article-title":"Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations","year":"2008"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1086\/512242","article-title":"Relapses of <italic>Plasmodium<\/italic> <italic>vivax<\/italic> infection result from clonal hypnozoites activated at predetermined intervals","volume":"195","author":"N Chen","year":"2007","journal-title":"J Infect Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/512241","article-title":"Relapses of <italic>Plasmodium<\/italic> <italic>vivax<\/italic> infection usually result from activation of heterologous hypnozoites","volume":"195","author":"M Imwong","year":"2007","journal-title":"J Infect Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4269\/ajtmh.1996.55.243","article-title":"Primaquine resistance in <italic>Plasmodium<\/italic> <italic>vivax<\/italic>","volume":"55","author":"WE Collins","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S1471-4922(02)02373-5","article-title":"The assessment of antimalarial drug efficacy","volume":"18","author":"NJ White","year":"2002","journal-title":"Trends Parasitol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/clpt.2011.254","article-title":"Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated <italic>falciparum<\/italic> malaria","volume":"91","author":"J Tarning","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1475-2875-10-297","article-title":"Determinants of relapse periodicity in <italic>Plasmodium<\/italic> <italic>vivax<\/italic> malaria","volume":"10","author":"NJ White","year":"2011","journal-title":"Malar J"},{"key":"ref54","article-title":"Multivariate analysis: a practical guide for clinicians","author":"MH Katz","year":"1999"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/AAC.48.8.2787-2792.2004","article-title":"Hazard ratio in clinical trials","volume":"48","author":"SL Spruance","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1475-2875-9-273","article-title":"Declining in efficacy of a three-day combination regimen of mefloquine artesunate in a multi-drug resistance area along the Thai-Myanmar border","volume":"9","author":"K Na-Bangchang","year":"2010","journal-title":"Malar J"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1475-2875-9-212","article-title":"The pharmaceutical death-ride of dihydroartemisinin","volume":"9","author":"FH Jansen","year":"2010","journal-title":"Malar J"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1128\/AAC.48.11.4271-4280.2004","article-title":"In vivo assessment of drug efficacy against <italic>Plasmodium<\/italic> <italic>falciparum<\/italic> malaria: duration of follow-up","volume":"48","author":"K Stepniewska","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/AAC.05688-11","article-title":"In vitro cardiovascular effects of dihydroartemisin-piperaquine combination compared with other antimalarials","volume":"56","author":"F Borsini","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0078819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T07:21:13Z","timestamp":1564903273000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0078819"}},"subtitle":[],"editor":[{"given":"Delmiro","family":"Fernandez-Reyes","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,3]]},"references-count":59,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0078819","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,3]]}}}